Structural architecture of PfCBD-D and hypothetical models of... | Download Scientific Diagram
Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB2 Receptor Derived from the Natural Product Cannabidiol | Journal of Medicinal Chemistry
Allosteric pluripotency as revealed by protein kinase A | Science Advances
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD) - Peng - 2022 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
THC vs. CBD: Which Is Right for You? | Ozark MMJ Cards
New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts | Cell Death Discovery
Diversity of molecular targets and signaling pathways for CBD - Almeida - 2020 - Pharmacology Research & Perspectives - Wiley Online Library
Can CBD Negate your THC High? | Cannabis Sciences
Frontiers | Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study | PLOS ONE
What's the Difference Between THC and CBD? Medical Marijuana THC
Inhibition by allosteric partial agonists through perturbation of... | Download Scientific Diagram
Frontiers | Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease
Molecules | Free Full-Text | Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol—A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling
Biomolecules | Free Full-Text | Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
Translational potential of allosteric modulators targeting the cannabinoid CB1 receptor | Acta Pharmacologica Sinica
Potential receptor mechanisms underlying CBD's action against drug... | Download Scientific Diagram
Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study | PLOS ONE
Cannabinoid Receptor Pharmacology
